REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $261,527 | +12.1% | 2,565 | 0.0% | 0.05% | +9.3% |
Q1 2023 | $233,210 | -9.6% | 2,565 | 0.0% | 0.04% | -8.5% |
Q3 2021 | $258,000 | -28.9% | 2,565 | 0.0% | 0.05% | -25.4% |
Q2 2021 | $363,000 | +41.8% | 2,565 | 0.0% | 0.06% | +28.6% |
Q1 2021 | $256,000 | -46.2% | 2,565 | -33.3% | 0.05% | -52.0% |
Q4 2020 | $476,000 | +26.9% | 3,848 | 0.0% | 0.10% | +4.1% |
Q3 2020 | $375,000 | -37.5% | 3,848 | 0.0% | 0.10% | -39.9% |
Q2 2020 | $600,000 | +8.1% | 3,848 | 0.0% | 0.16% | -15.5% |
Q1 2020 | $555,000 | -47.1% | 3,848 | -25.0% | 0.19% | -37.9% |
Q4 2019 | $1,049,000 | – | 5,131 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |